A tiny three-amino-acid peptide with serious anti-inflammatory power. It's especially effective for gut inflammation, making it a go-to for conditions like IBD and other inflammatory gut issues. Also helps calm down whole-body inflammation.
What to Expect
Week 1–2
Reduction in systemic inflammation markers. If targeting gut, mild reduction in bloating and discomfort. Anti-inflammatory effects beginning.
Week 3–6
Significant improvement in inflammatory gut conditions. Reduced skin inflammation (psoriasis, eczema). Improved mucosal barrier integrity measurable.
Week 8+
Sustained inflammation control. Gut barrier healing. Reduced frequency and severity of autoimmune flares. Improved overall immune balance.
Common Side Effects
Scientific Overview
KPV is a C-terminal tripeptide (Lys-Pro-Val) derived from alpha-melanocyte stimulating hormone (α-MSH). It retains the potent anti-inflammatory properties of α-MSH without melanotropic activity. KPV inhibits NF-κB nuclear translocation and reduces production of pro-inflammatory cytokines including IL-1β, IL-6, and TNF-α. It has demonstrated efficacy in inflammatory bowel disease models by reducing mucosal inflammation and promoting epithelial barrier integrity. KPV can cross cell membranes and directly interact with intracellular inflammatory signaling cascades.
Dosing
200-500 mcg oral or subq daily. Take it by mouth if you're targeting the gut specifically. Cycle for 4-8 weeks.
Practical Guide
Reconstitution
Mix 5mg vial with 1-2mL BAC water. Typical dose is 200-500mcg.
Storage
Refrigerate after reconstitution. Use within 21-30 days.
Injection Sites
Subcutaneous with insulin syringe. Oral capsules available for gut-targeted anti-inflammatory effects.
Timing
Once or twice daily. Morning and evening dosing for inflammatory conditions. Consistent timing.
Food
Oral: take on empty stomach for gut inflammation. Injectable: no food interactions.
Benefit Profile
Medical Considerations
Contraindications
- ✕Pregnancy/nursing
- ✕Active immunosuppressive therapy (opposing mechanisms)
Drug Interactions
Recommended Monitoring
- →Inflammatory markers (CRP, ESR) for efficacy tracking
- →GI symptoms log if treating gut inflammation
This information is for educational purposes only. Always consult a qualified healthcare provider before starting any peptide protocol.
Published Research
Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns.
Host defense peptides as a new drug lead to a strategy for inflammatory bowel disease.
Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review.
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials.
Terminal signal: anti-inflammatory effects of α-melanocyte-stimulating hormone related peptides beyond the pharmacophore.
Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases.
New insights into the functions of alpha-MSH and related peptides in the immune system.
The neuroimmunomodulatory peptide alpha-MSH.
The neuropeptide alpha-MSH in host defense.
NLRP3 autophagic degradation disruption in melanocytes contributes to vitiligo development.